Cargando…

Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study

BACKGROUND: Anti-tuberculosis (anti-TB) drug-induced liver injury (ADLI) is one of the most common adverse effects associated with TB treatment. Cytochrome P450 (CYP) 1A1 and glutathione S-transferase (GST) P1 are important phase I/II metabolizing enzymes involved in drug metabolism and detoxificati...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lei, Gao, Li, Shi, Zhe, Li, Yuhong, Zhu, Lingyan, Li, Shiming, Zhang, Peng, Zheng, Guoying, Ren, Qi, Li, Yun, Hu, Bo, Feng, Fumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370371/
https://www.ncbi.nlm.nih.gov/pubmed/25798582
http://dx.doi.org/10.1371/journal.pone.0119481
_version_ 1782362859657756672
author He, Lei
Gao, Li
Shi, Zhe
Li, Yuhong
Zhu, Lingyan
Li, Shiming
Zhang, Peng
Zheng, Guoying
Ren, Qi
Li, Yun
Hu, Bo
Feng, Fumin
author_facet He, Lei
Gao, Li
Shi, Zhe
Li, Yuhong
Zhu, Lingyan
Li, Shiming
Zhang, Peng
Zheng, Guoying
Ren, Qi
Li, Yun
Hu, Bo
Feng, Fumin
author_sort He, Lei
collection PubMed
description BACKGROUND: Anti-tuberculosis (anti-TB) drug-induced liver injury (ADLI) is one of the most common adverse effects associated with TB treatment. Cytochrome P450 (CYP) 1A1 and glutathione S-transferase (GST) P1 are important phase I/II metabolizing enzymes involved in drug metabolism and detoxification. Genetic polymorphism and CpG island methylation have been reported as factors influencing the expression of CYP1A1 and GSTP1. OBJECTIVE: This study aimed to determine the potential relationships of CYP1A1 and GSTP1 polymorphisms and CpG island methylation with ADLI risk. DESIGN: This was a population-based one-to-one matched case–control study. SETTING: The subjects were patients with TB receiving treatment in China from December 2010 to June 2013. PATIENTS: In total, 127 patients with TB and ADLI (case group) and 127 patients with TB but without liver injury (control group) were included in this study. Subjects were matched in terms of sex, age, and therapeutic regimen. METHODS: The general condition of each patient was assessed using questionnaires. The CYP1A1 MspI and GSTP1 Ile105Val polymorphisms as well as methylation status were detected by polymerase chain reaction (PCR)–restriction fragment length polymorphism and the methylation-specific PCR method. RESULTS: We found no significant difference in GSTP1 and CYP1A1 genotypes between the two groups, probably because the sample size was not large enough; however, patients with ADLI had significantly higher GSTP1 and CYP1A1 promoter methylation rates than control subjects [odds ratio (OR) = 2.467 and 2.000, respectively]. After adjusting for drinking, which significantly differed between the groups as per univariate analysis, we found that hypermethylation of GSTP1 and CYP1A1 promoters was associated with ADLI (OR = 2.645 and 2.090, respectively). CONCLUSION: Hypermethylation of CpG islands of GSTP1 and CYP1A1 promoters may thus play important roles in the development of ADLI and provide evidence of being used as novel markers for ADLI risk prediction.
format Online
Article
Text
id pubmed-4370371
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43703712015-04-04 Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study He, Lei Gao, Li Shi, Zhe Li, Yuhong Zhu, Lingyan Li, Shiming Zhang, Peng Zheng, Guoying Ren, Qi Li, Yun Hu, Bo Feng, Fumin PLoS One Research Article BACKGROUND: Anti-tuberculosis (anti-TB) drug-induced liver injury (ADLI) is one of the most common adverse effects associated with TB treatment. Cytochrome P450 (CYP) 1A1 and glutathione S-transferase (GST) P1 are important phase I/II metabolizing enzymes involved in drug metabolism and detoxification. Genetic polymorphism and CpG island methylation have been reported as factors influencing the expression of CYP1A1 and GSTP1. OBJECTIVE: This study aimed to determine the potential relationships of CYP1A1 and GSTP1 polymorphisms and CpG island methylation with ADLI risk. DESIGN: This was a population-based one-to-one matched case–control study. SETTING: The subjects were patients with TB receiving treatment in China from December 2010 to June 2013. PATIENTS: In total, 127 patients with TB and ADLI (case group) and 127 patients with TB but without liver injury (control group) were included in this study. Subjects were matched in terms of sex, age, and therapeutic regimen. METHODS: The general condition of each patient was assessed using questionnaires. The CYP1A1 MspI and GSTP1 Ile105Val polymorphisms as well as methylation status were detected by polymerase chain reaction (PCR)–restriction fragment length polymorphism and the methylation-specific PCR method. RESULTS: We found no significant difference in GSTP1 and CYP1A1 genotypes between the two groups, probably because the sample size was not large enough; however, patients with ADLI had significantly higher GSTP1 and CYP1A1 promoter methylation rates than control subjects [odds ratio (OR) = 2.467 and 2.000, respectively]. After adjusting for drinking, which significantly differed between the groups as per univariate analysis, we found that hypermethylation of GSTP1 and CYP1A1 promoters was associated with ADLI (OR = 2.645 and 2.090, respectively). CONCLUSION: Hypermethylation of CpG islands of GSTP1 and CYP1A1 promoters may thus play important roles in the development of ADLI and provide evidence of being used as novel markers for ADLI risk prediction. Public Library of Science 2015-03-23 /pmc/articles/PMC4370371/ /pubmed/25798582 http://dx.doi.org/10.1371/journal.pone.0119481 Text en © 2015 He et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
He, Lei
Gao, Li
Shi, Zhe
Li, Yuhong
Zhu, Lingyan
Li, Shiming
Zhang, Peng
Zheng, Guoying
Ren, Qi
Li, Yun
Hu, Bo
Feng, Fumin
Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title_full Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title_fullStr Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title_full_unstemmed Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title_short Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case–Control Study
title_sort involvement of cytochrome p450 1a1 and glutathione s-transferase p1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370371/
https://www.ncbi.nlm.nih.gov/pubmed/25798582
http://dx.doi.org/10.1371/journal.pone.0119481
work_keys_str_mv AT helei involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT gaoli involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT shizhe involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT liyuhong involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT zhulingyan involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT lishiming involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT zhangpeng involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT zhengguoying involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT renqi involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT liyun involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT hubo involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy
AT fengfumin involvementofcytochromep4501a1andglutathionestransferasep1polymorphismsandpromoterhypermethylationintheprogressionofantituberculosisdruginducedliverinjuryacasecontrolstudy